Drug Approval Package
-
Invanz
I.V. or I.M. (Ertapenem Sodium)
Company: Merck & Co., Inc.
Application No.: 21-337
Approval Date: 11/21/01
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Medical Review(s)
Part 1 (PDF) Part 5 (PDF) Part 9 (PDF) Part 2 (PDF) Part 6 (PDF) Part 10 (PDF) Part 3 (PDF) Part 7 (PDF) Part 11 (PDF) Part 4 (PDF) Part 8 (PDF) Part 12 (PDF) -
Chemistry Review(s) (PDF)
-
Pharmacology Review(s) (PDF)
-
Microbiology Review(s) (PDF)
Date created: November 20, 2001
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-